Inventor profile of:

Michael J. WELSH

City:

Riverside, Iowa

Country:

United States

Published Applications:

23

Last publication date:

2024-03-28

Top Assignees for applications by Michael J. WELSH

The entities that hold a legal rights for patent applications filed by inventor WELSH Michael J.:

Recent patent applications by WELSH Michael J.

Michael J. WELSH from Riverside, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-03-28
US20240100183A1
Human necessities

COMPOSITIONS COMPRISING MOLECULES FOR CYSTIC FIBROSIS TREATMENT

#2 | 2022-01-06
US20220000871A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES USING MODULATORS OF PHOSPHOGLYCERATE KINASE 1 (PGK1) ACTIVITY

#3 | 2017-09-14
US20170258058A1
Human necessities

Transgenic pig models of cystic fibrosis

#4 | 2014-09-11
US20140255975A1
Human necessities

Transgenic pig models of cystic fibrosis

#5 | 2013-11-28
US20130316022A1
Human necessities

METHOD TO ENHANCE ANTIMICROBIAL ACTIVITY BY INCREASING pH

#6 | 2013-08-15
US20130210708A1
Human necessities

METHODS OF INHIBITING AND TREATING BACTERIAL BIOFILMS BY METAL CHELATORS

#7 | 2012-07-12
US20120180141A1
Chemistry; metallurgy

Transgenic pig model of cystic fibrosis

#8 | 2012-06-07
US20120142583A1
Human necessities

Methods of inhibiting and treating bacterial biofilms by metal chelators

#9 | 2012-01-19
US20120015396A1
Physics

COMPOSITIONS AND METHODS FOR MODULATING THE ACID-SENSING ION CHANNEL (ASIC)

#10 | 2011-03-03
US20110054247A1
Chemistry; metallurgy

METHODS FOR CLONING FERRETS AND TRANSGENIC FERRET MODELS FOR DISEASES

#11 | 2009-11-26
US20090291150A1
Human necessities

METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING SEIZURES BY MODULATING ACID-SENSING ION CHANNEL ACTIVITY

#12 | 2009-09-24
US20090241206A1
Chemistry; metallurgy

METHODS FOR CLONING FERRETS AND TRANSGENIC FERRET MODELS FOR DISEASES

#13 | 2009-09-24
US20090241203A1
Chemistry; metallurgy

Transgenic porcine models of cystic fibrosis

#14 | 2009-09-17
US20090235368A1
Human necessities

Method of identifying compounds using a transgenic pig model of cystic fibrosis

#15 | 2009-09-10
US20090227769A1
Chemistry; metallurgy

CFTR with a partially deleted R domain and uses thereof

#16 | 2008-12-25
US20080318320A1
Chemistry; metallurgy

Targeting vector to the urokinase plasminogen activator receptor

#17 | 2008-03-04
US10367507
-

CFTR with a partially deleted R domain and uses thereof

#18 | 2007-08-23
US20070197583A1
Physics

Novel compositions and methods for modulation of the acid-sensing ion channel (ASIC) for the treatment of anxiety and drug addiction

#19 | 2007-05-03
US20070098690A1
Chemistry; metallurgy

Truncated CMV promoters and vectors containing same

#20 | 2007-04-19
US20070087964A1
Physics

NOVEL COMPOSITIONS AND METHODS FOR MODULATING THE ACID-SENSING ION CHANNEL (ASIC)

#21 | 2006-11-07
US10442880
-

Targeting vector to the urokinase plasminogen activator receptor

#22 | 2006-08-24
US20060189701A1
Human necessities

Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections

#23 | 2005-06-30
US20050143286A1
Human necessities

Methods of inhibiting and treating bacterial biofilms by metal chelators

InventorID:

390911 ⎘